Abbott Laboratories
Pharmaceutical or Nutritional Combination Comprising Beta-Hydroxy-Betamethylbutyrate
Last updated:
Abstract:
The present invention relates to a pharmaceutical or nutritional combination comprising beta-hydroxy beta-methylbutyrate (HMB) and tetrahydrocurcumin (THC) and methods comprising administering the combination to a subject. The methods of the invention relate to attenuating muscle protein degradation and/or preserving lean body mass in the subject.
Status:
Application
Type:
Utility
Filling date:
16 Jan 2017
Issue date:
22 Jul 2021